文献

J-GLOBAL ID：202002239803083264   整理番号：20A2241774

同種造血幹細胞移植後の早期高ビリルビン血症患者の転帰

Outcomes of Patients with Early Hyperbilirubinemia after Allogeneic Hematopoietic Stem Cell Transplantation

著者 (15件)： Omori Ikuko (Department of Hematology, Nippon Medical School) ,  Yamaguchi Hiroki (Department of Hematology, Nippon Medical School) ,  Hirakawa Tsuneaki (Department of Hematology, Nippon Medical School) ,  Inai Kazuki (Department of Hematology, Nippon Medical School) ,  Onai Daishi (Department of Hematology, Nippon Medical School) ,  Marumo Atsushi (Department of Hematology, Nippon Medical School) ,  Yamanaka Satoshi (Department of Hematology, Nippon Medical School) ,  Sakaguchi Masahiro (Department of Hematology, Nippon Medical School) ,  Fujiwara Yusuke (Department of Hematology, Nippon Medical School) ,  Wakita Satoshi (Department of Hematology, Nippon Medical School) ,  Okamoto Muneo (Department of Hematology, Nippon Medical School) ,  Tamai Hayato (Department of Hematology, Nippon Medical School) ,  Nakayama Kazutaka (Department of Hematology, Nippon Medical School) ,  Yui Shunsuke (Department of Hematology, Nippon Medical School) ,  Inokuchi Koiti (Department of Hematology, Nippon Medical School)
資料名： Journal of Nippon Medical School  (Journal of Nippon Medical School)
巻： 87  号： 3  ページ： 142-152(J-STAGE)  発行年： 2020年 
JST資料番号： F0887A  ISSN： 1345-4676  CODEN： JNMSF5  資料種別： 逐次刊行物 (A)
記事区分： 原著論文  発行国： 日本 (JPN)  言語： 英語 (EN)

抄録/ポイント： 背景:同種造血幹細胞移植(HSCT)後の肝機能障害の原因は初...

シソーラス用語： ヒト ,...
準シソーラス用語： *同種造血幹細胞移植 ,...

ログイン（無料）して見る     続きはJDreamIII（有料）にて  {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=20A2241774&from=J-GLOBAL&jstjournalNo=F0887A") }}

著者キーワード (3件)： 肝機能障害 ,  同種造血幹細胞移植 ,  総ビリルビン

分類 (2件)： 消化器の疾患  (GH03000W) ,  血液疾患の治療一般  (GK05010E)

引用文献 (11件)：

• 1. McDonald GB. Hepatobiliary complications of hematopoietic cell transplantation, 40 years on. Hepatology. 2010;51:1450-60.
• 2. McDonald GB. Advances in prevention and treatment of hepatic disorders following hematopoietic cell transplantation. Best Pract Res Clin Haematol. 2006;19 (2):341-52.
• 3. Arai Y, Kanda J, Nakasone H, et al. GVHD working group of the Japan Society for Hematopoietic Cell Transplantation: Risk factors and prognosis of hepatic acute GvHD after allogeneic hematopoietic cell transplantation. Bone Marrow Transplant. 2016;51:96-102.
• 4. Richardson PG, Elias AD, Krishnan A, et al. Treatment of severe veno-occlusive disease with defibrotide: compassionate use results in response without significant toxicity in a high-risk population. Blood. 1998;92:737-44.
• 5. Richardson PG, Riches ML, Kernan NA, et al. Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure. Blood. 2016;127 (13):1656-65.

タイトルに関連する用語 (4件)： 同種造血幹細胞移植 ,  早期 ,  高ビリルビン血症 ,  患者の転帰